Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts

James E. Littlejohn, Xiaobo Cao, Steven D. Miller, Mustafa K. Ozvaran, Daniel Jupiter, Lidong Zhang, Charles Rodarte, W. Roy Smythe

Research output: Contribution to journalArticle

22 Scopus citations

Fingerprint Dive into the research topics of 'Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts'. Together they form a unique fingerprint.

Medicine & Life Sciences